Ocular Surface Disease and Dry Eye Clinic
This specialized team is dedicated to providing cutting-edge diagnostic testing and procedure-based treatments for the medical management of dry eye disease across multiple Wilmer locations.
By age 18, Henry Harten was legally blind, the result of a rare genetic disorder. Meet Henry and the team whose careful collaboration allowed him to see the world clearly for the first time.
In the News'Not Satisfied with the Status Quo'
Dr. Albert Jun is using a gene editing technique known as CRISPR to understand and someday cure granular corneal dystrophy.
I see the division building upon the energy and intellect of faculty, both junior and senior, who seek to be global leaders in their chosen areas of clinical and academic focus. In this way, we will establish the breadth and depth of expertise necessary to be the world leader in cornea, cataract and external disease care.- Dr. Albert Jun, Chief, Division of Cornea, Cataract and External Eye Diseases
In the NewsPartnering to Restore Sensation
Until recently, people with neurotrophic corneas could receive treatment for symptoms but not for the root cause. That changed with a Johns Hopkins collaboration between Wilmer and the Department of Plastic and Reconstructive Surgery.